Teva Continues Restructuring With 46 Cuts in Pennsylvania Post author:Sam Post published:February 7, 2018 Post category:BioPharma The cuts were apparently announced in late January with a WARN notice filed with the state. Source: BioSpace You Might Also Like The Leukemia & Lymphoma Society Appoints As Chief Medical Officer March 16, 2017 Bay Area's Coherus Craters After the FDA Spurns Its Biosimilar for Amgen's Neulasta June 11, 2017 Charles River Laboratories: Business Is Booming With 500 Positions Open May 4, 2017